Lane Peter R. 4
4 · Goosehead Insurance, Inc. · Filed Aug 24, 2020
Insider Transaction Report
Form 4
Lane Peter R.
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2020-08-20$10.00/sh+30,000$300,000→ 30,000 total - Sale
Class A Common Stock
2020-08-20$100.67/sh−13,073$1,316,119→ 700 total - Sale
Class A Common Stock
2020-08-20$99.77/sh−16,227$1,619,007→ 13,773 total - Exercise/Conversion
Director Stock Options (right to buy)
2020-08-20−30,000→ 91,622 totalExercise: $10.00Exp: 2028-04-26→ Class A Common Stock (30,000 underlying) - Sale
Class A Common Stock
2020-08-20$101.95/sh−700$71,368→ 0 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.34 to $100.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.36 to $101.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.72 to $102.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date; provided, that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the issuer's omnibus incentive plan).